EUVIMEDEUVIMED entdecken
Crossref

Baseline OCT Biomarkers Associated with Anatomical Response and Long-Term Reinjection Burden in Diabetic Macular Edema Treated with Intravitreal Dexamethasone Implant

Ozge Saritas, Piraye Dundar, Esra Yigit Gokpinar, Yelda Yildiz Tasci, Yasin Toklu

International Ophthalmology · 13.11.2026 · 46 (1)

DOI: 10.1007/s10792-026-04313-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Ophthalmology, online erschienen am 13.11.2026. Verfasst von Ozge Saritas und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Faculty of Medicine, Ankara Yıldırım Beyazıt University, Ankara, Turkey. ozgesaritas@aybu.edu.tr. Hauptthemen laut MEDLINE: Dexamethasone, Macular Edema, Tomography, Optical Coherence, Diabetic Retinopathy. Die Arbeit nennt 33 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: To identify baseline optical coherence tomography (OCT) biomarkers associated with 6 month anatomical response and 36 month reinjection burden in anti-vascular endothelial growth factor (anti-VEGF)-pretreated eyes with diabetic macular edema (DME) switched to dexamethasone (DEX) implant. METHODS: This retrospective single-center cohort included 130 eyes (130 patients) followed for 36 months. Good 6 month anatomical response was defined as a ≥ 20% reduction in central subfield thickness (CST) with complete resolution of intraretinal and subretinal fluid, and frequent reinjection as ≥ 5 DEX implants within 36 months. Multivariable logistic regression was used (Firth penalized regression for reinjection), with a CST-independent fluid-resolution endpoint used as sensitivity analysis. RESULTS: Sixty eyes (46.2%) achieved good anatomical response. Hyperreflective foci (HRF; OR 0.12, 95% CI 0.02-0.48), disorganization of the retinal inner layers (DRIL; OR 0.16, 0.05-0.47), and external limiting membrane (ELM) disruption (OR 0.16, 0.04-0.54) were independently associated with lower odds of response (optimism-corrected AUC 0.88) and remained significant for fluid resolution. Seventy-nine eyes (60.8%) received ≥ 5 implants. Ellipsoid zone (EZ) disruption (OR 24.83, 3.73-345.08) and DRIL (OR 5.03, 1.45-20.27) were independently associated with frequent reinjection (optimism-corrected AUC 0.95). Month-6 and month-36 anatomical status agreed in 85.4% of eyes. Intraocular pressure > 25 mmHg occurred in 26.2% of eyes, all controlled medically. CONCLUSION: Baseline OCT biomarkers were associated with both early anatomical response and long-term reinjection burden after switching to DEX. HRF, DRIL, and ELM disruption were associated with a lower likelihood of 6 month response, whereas EZ disruption and DRIL were associated with a higher 36 month reinjection burden. These prognostic associations require external validation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DexamethasoneMacular EdemaTomography, Optical CoherenceDiabetic RetinopathyVisual AcuityHumansRetrospective StudiesDrug ImplantsFemaleGlucocorticoidsIntravitreal InjectionsMaleBiomarkersFollow-Up StudiesMiddle AgedTime FactorsTreatment OutcomeAged

Stichwörter der Autor:innen

Dexamethasone intravitreal implantDiabetic macular edemaDisorganization of retinal inner layersEllipsoid zoneOptical coherence tomographyReinjection burden

Substanzen

DexamethasoneDrug ImplantsGlucocorticoidsBiomarkers

Autor:innen und Institutionen

  • Department of Ophthalmology, Faculty of Medicine, Ankara Yıldırım Beyazıt University, Ankara, Turkey. ozgesaritas@aybu.edu.tr.
  • Department of Ophthalmology, Bilkent City Hospital, Ankara, Turkey.
  • Department of Statistics, Gazi University, Ankara, Turkey.
  • Department of Ophthalmology, Faculty of Medicine, Ankara Yıldırım Beyazıt University, Ankara, Turkey.

Zitieren

APA

Saritas, O., Dundar, P., Gokpinar, E. Y., Tasci, Y. Y., & Toklu, Y. (2026). Baseline OCT Biomarkers Associated with Anatomical Response and Long-Term Reinjection Burden in Diabetic Macular Edema Treated with Intravitreal Dexamethasone Implant. International Ophthalmology, 46(1). https://doi.org/10.1007/s10792-026-04313-2

Vancouver

Saritas O, Dundar P, Gokpinar EY, Tasci YY, Toklu Y. Baseline OCT Biomarkers Associated with Anatomical Response and Long-Term Reinjection Burden in Diabetic Macular Edema Treated with Intravitreal Dexamethasone Implant. International Ophthalmology. 2026;46(1). doi:10.1007/s10792-026-04313-2

BibTeX
@article{Saritas2026,
  author = {Saritas, Ozge and Dundar, Piraye and Gokpinar, Esra Yigit and Tasci, Yelda Yildiz and Toklu, Yasin},
  title = {Baseline OCT Biomarkers Associated with Anatomical Response and Long-Term Reinjection Burden in Diabetic Macular Edema Treated with Intravitreal Dexamethasone Implant},
  journal = {International Ophthalmology},
  year = {2026},
  volume = {46},
  number = {1},
  doi = {10.1007/s10792-026-04313-2}
}
Kostenlos starten →